1. bookVolumen 63 (2013): Edición 2 (June 2013)
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
ISSN
1330-0075
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

Chemometrically assissted optimization and validation of RP-HPLC method for the analysis of itraconazole and its impurities

Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
ISSN
1330-0075
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés

1. A. M. Siouffi and R. Phan-Tan-Luu, Optimization methods in chromatography and capillary electrophoresis, J. Chromatogr. A 892 (2000) 75-106; DOI: 10.1016/S0021-9673(00)00247-8.10.1016/S0021-9673(00)00247-8Search in Google Scholar

2. A. Malenović, Y. Dotsikas, M. Mašković, B. Jančić Stojanović, D. Ivanović and M. Medenica, Desirability-based optimization and its sensitivity analysis for the perindopril and its impurities analysis in a microemulsion LC system, Microchem. J. 99 (2011) 454-460; DOI: 10.1016/j.microc. 2011.06.022.Search in Google Scholar

3. M. A. Bezerra, R. E. Santelli, E. P. Oliveira, L. S. Villar and L. A. Escaleira, Response surface methodology (RSM) as a tool for optimization in analytical chemistry, Talanta 76 (2008) 965-977; DOI: 10.1016/j.talanta.2008.05.019.10.1016/j.talanta.2008.05.019Search in Google Scholar

4. S. L. C. Ferreira, W. N. L. Dos Santos, C. M. Quintella, B. B. Neto and J. M. Bosque-Sendra, Doehlert matrix: A chemometric tool for analytical chemistry-Review, Talanta 63 (2004) 1061-1067; DOI: 10.1016/j.talanta.2004.01.015.10.1016/j.talanta.2004.01.015Search in Google Scholar

5. Y. Vander Heyden and D. L. Massart, Review of the Use of Robustness and Ruggedness in AnalyticalChemistry, in Robustness of Analytical Chemical Methods and Pharmaceutical Technological Products (Eds. M. W. B. Hendriks, J. H. De Boer and A. K. Smilde), Elsevier, Amsterdam 1996.10.1016/S0922-3487(96)80016-5Search in Google Scholar

6. Y. VanderHeyden, A. Nijhuis, J. Smeyers-Verbeke, B. G. M. Vandeginste and D. L. Massart, Guidance for robustness/ruggedness tests in method validation, J. Pharm. Biomed. Anal. 24 (2001) 723-753; DOI: 10.1016/S0731-7085(00)00529-X.10.1016/S0731-7085(00)00529-XSearch in Google Scholar

7. M. Mašković, B. Jančić-Stojanović, A. Malenović, D. Ivanović and M. Medenica, Assessment of liquid chromatographic method robustness by use of Plackett-Burman design, Acta Chromatogr. 22 (2010) 281-296; DOI: 10.1556/AChrom.22.2010.2.10.10.1556/AChrom.22.2010.2.10Search in Google Scholar

8. T. Rakić, A. Malenović, B. Jančić-Stojanović, D. Ivanović and M. Medenica, Avoiding the false negative results in LC method robustness testing by modifications of the algorithm of Dong and dummy factor effects approach, Chromatographia 75 (2012) 397-401; DOI: 10.1007/s10337-012-2196-6.10.1007/s10337-012-2196-6Search in Google Scholar

9. European Pharmacopeia, 7th ed., Council of Europe, Strasbourg 2011, pp. 2297-2299.Search in Google Scholar

10. M. Dumarey, R. Sneyers, W. Janssens, I. Somers and Y. Vander Heyden, Drug impurity profiling: Method optimization on dissimilar chromatographic systems: Part I: pH optimization of the aqueous phase, Anal. Chim. Acta 656 (2009) 85-92; DOI: 10.1016/j.aca.2009.10.013.10.1016/j.aca.2009.10.013Search in Google Scholar

11. D. Compas, D. J. Touw and P. N. F. C. de Goede, Rapid method for the analysis of itraconazole and hydroxyitraconazole in serum by high-performance liquid chromatography, J. Chromatogr. B 687 (1996) 453-456; DOI: 10.1016/S0378-4347(96)00245-9.10.1016/S0378-4347(96)00245-9Search in Google Scholar

12. C. H. W. Koks, R. W. Sparidans, G. Lucassen, K. M. L. Crommentuyn and J. H. Beijnen, Selective high-performance liquid chromatographic assay for itraconazole and hydroxyitraconazole in plasma from human immunodeficiency virus-infected patients, J. Chromatogr. B 767 (2002) 103-110; DOI: 10.1016/S0378-4347(01)00550-3.10.1016/S0378-4347(01)00550-3Search in Google Scholar

13. V. Srivatsan, A. K. Dasgupta, P. Kale, R. R. Datla, D. Soni, M. Patel, R. Patel and C. Mavadhiya, Simultaneous determination of itraconazole and hydroxyitraconazole in human plasma by high- -performance liquid chromatography, J. Chromatogr. A 1031 (2004) 307-313; DOI: 10.1016/j.chroma. 2003.11.061.Search in Google Scholar

14. T. Uno, M. Shimizu, K. Sugawara and T. Tateishi, Sensitive determination of itraconazole and its active metabolite in human plasma by column-switching high-performance liquid chromatography with ultraviolet detection, Ther. Drug Monit. 28 (2006) 526-531; DOI: 10.1097/00007691-200608000-00007.10.1097/00007691-200608000-00007Search in Google Scholar

15. P. Kubalec and E. Brandšteterová, Column-switching chromatographic determination of itraconazole and its metabolite hydroxy-itraconazole in human serum, Pharmazie 56 (2001) 397-400.Search in Google Scholar

16. W. C. Young, D. Nam, H. K. Kyoung, W. H. Kyung, H. H. In, K. C. Byung, M. Yoon and J. Lee, High-performance liquid chromatographic-tandem mass spectrometric determination of itraconazole in human plasma for bioavailability and bioequivalence studies, Bull. Korean Chem. Soc.27 (2006) 291-294; DOI: 10.5012/bkcs.2006.27.2.291.10.5012/bkcs.2006.27.2.291Search in Google Scholar

17. L. Bai, M. M. Li, C. J. Zhao and T. T. Ma, Determination of itraconazole in human plasma by HPLC and studies of bioequivalence, Chinese Pharmaceut. J. 43 (2008) 1272-1274.Search in Google Scholar

18. J.W.Wong, U. R. Nisar and K. H. Yuen, Liquid chromatographic method for the determination of plasma itraconazole and its hydroxy metabolite in pharmacokinetic/bioavailability studies, J. Chromatogr. B 798 (2003) 355-360; DOI: 10.1016/j.jchromb.2003.09.059.10.1016/j.jchromb.2003.09.059Search in Google Scholar

19. L. Baietto, A. D’Avolio, G. Ventimiglia, F. G. De Rosa, M. Siccardi, M. Simiele, M. Sciandra and G. Di Perri, Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma, Antimicrob. Agents Chemother. 54 (2010) 3408-3413; DOI: 10.1128/AAC.01807-09. 10.1128/AAC.01807-09Search in Google Scholar

20. W. Chen, B. Gu, H. Wang, J. Pan,W. Lu and H. Hou. Development and evaluation of novel itraconazole- loaded intravenous nanoparticles, Int. J. Pharm. 362 (2008) 133-140; DOI: 10.1016/j.ijpharm. 2008.05.039.Search in Google Scholar

21. L. Gagliardi, D. De Orsi, P. Chimenti, R. Porra and D. Tonelli, HPLC determiantion of imidazole antimycotics in antidandruff cosmetic products, Anal. Sci. 19 (2003) 11951197; DOI: 10.2116/analsci. 19.1195.Search in Google Scholar

22. S. L. C. Ferreira, R. E. Bruns, E. G. P. da Silva, W. N. L. dos Santos, C. M. Quintella, J. M. Davis, J. B. de Andrade, M. C. Breitkreitz, I. C. S. F. Jardim and B. B. Neto, Statistical designs and response surface techniques for the optimization of chromatographic systems, J. Chromatogr. A 1158 (2007) 2-14; DOI: 10.1016/j.chroma.2007.03.051.10.1016/j.chroma.2007.03.051Search in Google Scholar

23. R. L. Mason, R. F. Gunst and J. L. Hess, Statistical Design and Analysis of Experiments With Applicationto Engineering and Science, 2nd ed., Hoboken, New York 2003.10.1002/0471458503Search in Google Scholar

24. G. C. Carle, Determination of chromatographic resolution for peaks of vast concentration differences, Anal. Chem. 44 (1972) 1905-1906.10.1021/ac60319a030Search in Google Scholar

25. R. E. Kaiser, Gas Chromatographie, Portig, Leipzig 1960, p. 33.10.1007/978-1-4684-8291-1_2Search in Google Scholar

26. F. Dong, On the identification of active contrasts in unreplicated fractional factorials, Stat. Sinica3 (1993) 209-217.Search in Google Scholar

27. J. B. Crowther, Validation of Pharmaceutical Test Methods, in Handbook of Modern PharmaceuticalAnalysis (Eds. S. Ahuja and S. Scypinski), Academic Press, New York 2001, pp. 415-443. 10.1016/S0149-6395(01)80014-3Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo